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ore models of membrane fusion postulate that cylinders
of integral membrane proteins can initiate a fusion
pore after conformational rearrangement of pore sub-
units. In the fusion of yeast vacuoles, V-ATPase V
 
0
 
 sectors,
which contain a central cylinder of membrane integral
proteolipid subunits, associate to form a transcomplex that
might resemble an intermediate postulated in some pore
models. We tested the role of V
 
0
 
 sectors in vacuole fusion.
V
 
0
 
 functions in fusion and proton translocation could be
experimentally separated via the differential effects of
mutations and inhibitory antibodies. Inactivation of the V
 
0
 
subunit Vph1p blocked fusion in the terminal reaction
P
 
stage that is independent of a proton gradient. 
 
 
 
vph1 mutants
were capable of docking and trans-SNARE pairing and of
subsequent release of lumenal Ca
 
2
 
 
 
, but they did not fuse.
The Ca
 
2
 
 
 
-releasing channel appears to be tightly coupled
to V
 
0
 
 because inactivation of Vph1p by antibodies blocked
 
Ca
 
2
 
 
 
 release. Vph1 deletion on only one fusion partner
sufﬁced to severely reduce fusion activity. The functional
requirement for Vph1p correlates to V
 
0
 
 transcomplex for-
mation in that both occur after docking and Ca
 
2
 
 
 
 release.
These observations establish V
 
0
 
 as a crucial factor in vacuole
fusion acting downstream of trans-SNARE pairing.
 
Introduction
 
The fusion of intracellular membranes depends on a pro-
teinaceous machinery which has been partially conserved in
evolution. Homologous components act on different stations
of membrane traffic in the secretory and endocytic pathways
(Gotte et al., 2000; Chen and Scheller, 2001; Pelham,
2001). This led to the suggestion that all intracellular fusion
reactions of eukaryotic cells might follow a universal reaction
mechanism implemented by variations of the same core
machinery, the SNARE proteins (Rothman, 1994). After
activation by the ATPase Sec18p/NSF, cognate SNAREs
from opposing membranes can form transcomplexes which
are believed to force the membranes into close apposition
and cause fusion. In line with this proposal, a basal fusion
activity of SNAREs could be reconstituted from purified
components inserted into liposomes (Weber et al., 1998).
 
The fusion of vacuoles from the yeast 
 
Saccharomyces cerevisiae
 
shares many key features with other fusion reactions (Mayer,
2001). Thus, it can serve to test hypotheses about the fusion
mechanism and about the role of specific conserved compo-
nents. Vacuole fusion depends on the activation of t- and
v-SNAREs by the ATPase Sec18p/NSF and its cofactor
Sec17p/
 
 
 
-SNAP and on a Rab-GTPase, Ypt7p (Haas et
al., 1995; Haas and Wickner, 1996; Mayer et al., 1996;
Ungermann et al., 1999a). Ypt7p cooperates with the
HOPS complex, an oligomeric assembly of tethering factors
containing the class C Vps proteins (Price et al., 2000ab;
Sato et al., 2000; Seals et al., 2000; Wurmser et al., 2000).
During priming, ATP hydrolysis by Sec18p/NSF disrupts
cis-SNARE complexes (Nichols et al., 1997; Ungermann et
al., 1998a) and yields SNAREs in a labile, activated state
which is stabilized by the LMA1 complex (Xu and Wickner,
1996; Slusarewicz et al., 1997; Xu et al., 1997, 1998). Prim-
ing also releases the armadillo repeat protein Vac8p from
SNAREs and triggers its palmitoylation (Veit et al., 2001;
Rohde et al., 2003), a modification that might be relevant to
the function of Vac8p in later stages of fusion (Wang et al.,
2000). Priming facilitates tethering, the initial and less stable
attachment of the fusion partners that depends on Ypt7p and
the HOPS complex (Mayer and Wickner, 1997; Ungermann
et al., 1998b; Price et al., 2000a). Specific interactions between
HOPS and SNAREs involve the NH
 
2
 
-terminal domain of
the SNARE Vam3p (Laage and Ungermann, 2001; Wang et
al., 2001a). Tethering is a prerequisite for subsequent docking,
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a tighter binding of vacuoles that requires SNAREs and
might involve the formation of trans-SNARE complexes,
i.e., complexes of cognate t- and v-SNAREs on the opposing
membranes (Ungermann et al., 1998b; Laage and Unger-
mann, 2001). Tethering and docking are accompanied by a
concentration of many fusion-relevant components around
the contact zones between vacuoles (Wang et al., 2002).
Trans-SNARE complexes accumulate to low abundance
during the fusion reaction (Ungermann et al., 1998b; Rohde
et al., 2003). An enormous advantage of the vacuole fusion
system is that trans-SNARE pairing can be directly assayed
as an intermediate which is well integrated into the reaction
pathway, a property that distinguishes it from the other ma-
jor systems used to study membrane fusion. Notably, trans-
SNARE pairs between vacuoles can be disassembled after
docking without blocking further progression of fusion (Un-
germann et al., 1998b). This indicates that SNAREs are re-
quired at least up to the docking stage but that trans-SNARE
pairing may be dispensable for completion of the reaction.
Priming and docking also show specific lipid require-
ments, in particular for phosphatidylinositol 4,5-bisphos-
phate (Mayer et al., 2000), ergosterol (Kato and Wickner,
2001), and phosphatidylinositol 3-phosphate (Cheever et
al., 2001; Boeddinghaus et al., 2002). Like exocytosis (Ad-
amo et al., 1999, 2001; Guo et al., 2001; Zhang et al.,
2001), vacuole fusion requires more than one small GTPase.
In addition to the Rab-GTPase Ypt7p, the Rho-GTPases
Cdc42p and Rho1p are involved (Eitzen et al., 2001; Muller
et al., 2001), probably by regulating the remodeling of vacu-
olar actin. Dynamic changes of vacuolar actin occur during
fusion (Eitzen et al., 2002; Seeley et al., 2002).
Vacuole docking triggers an efflux of calcium from the
lumen of the organelle which fosters the binding of cal-
modulin to the membranes (Peters and Mayer, 1998). Cal-
modulin binds to a high molecular weight complex which
contains the protein phosphatase 1 Glc7p (Peters et al.,
1999) and V
 
0
 
 sectors, the membrane integral part of the vac-
uolar H
 
 
 
-ATPase (V-ATPase). Calmodulin was also found
in association with the membrane integral VTC complex
(Peters et al., 2001). The VTC complex binds to the V-ATP-
ase, is required for the priming activity of Sec18p/NSF,
and influences the binding of LMA1 to the membrane
(Muller et al., 2002). VTC proteins may, therefore, couple
Sec18p/NSF to V
 
0
 
, perhaps to activate it for a potential role
in fusion. This speculation appears particularly attractive be-
cause a subset of V
 
0
 
 sectors, which is enriched in calmodulin
and in the vacuolar t-SNARE Vam3p, form transcomplexes.
V
 
0
 
 sectors from the opposing membranes bind to each other
before fusion has been completed (Peters et al., 2001). A
multimeric (probably hexameric) cylinder of proteolipids is
a central part of the V
 
0
 
 sector (Hirata et al., 1997; Powell et
al., 2000). Thus, V
 
0
 
 transcomplexes resemble the situation
postulated in some pore models of fusion (Lindau and Al-
mers, 1995; Mayer, 2001; Zimmerberg, 2001) which suggest
that continuous proteinaceous pores composed of multiple
subunits could mediate membrane fusion. This could occur,
for example, by radial expansion of the cylinder and partial
lateral separation of their subunits (Lindau and Almers,
1995) or by conformational changes of the pore subunits,
resulting in rotation or the transient shifting of hydrophobic
and hydrophilic surfaces (Zimmerberg, 2001). If vacuole fu-
sion followed this or a similar pathway, proteolipids or en-
tire V
 
0
 
 sectors should act in the postdocking phase of this
reaction. We have begun to test this hypothesis by manipu-
lating different V-ATPase subunits and assaying the effects
on vacuolar membrane fusion.
 
Results
 
Dissecting the role of V
 
0
 
 in vacuolar membrane fusion poses
the problem to separate the requirement for a proton motive
force (pmf)* from a direct involvement of V
 
0
 
 in bilayer fu-
sion. Completion of vacuole docking and trans-SNARE
pairing require a pmf (Ungermann et al., 1999b). However,
full V-ATPase proton pump activity is not required because
significant fusion activity remains after V-ATPase inactiva-
tion by chaotropic salts (Peters et al., 2001). This suggests
that a comparably low pmf may suffice to drive fusion which
could be satisfied by residual V-ATPase activity provided by
a fraction of intact V-ATPases below the detection limit.
More likely, however, alternative pathways create a pmf, for
example, by combination of ATP-driven ion or metabolite
transporters and proton-translocating antiporters. Many
such transport systems exist in vacuolar membranes. In any
case, the requirement for a basal pmf necessitates to test a di-
rect involvement of V
 
0
 
 in bilayer fusion under conditions in
which proton translocation activity of the V-ATPase is not
limiting for the reaction.
We pursued in vivo and in vitro approaches to address this
question. V-ATPase–deficient mutants die on neutral media
and survive with slow growth on acidic media (Stevens and
Forgac, 1997; Kane, 1999). Due to altered physiological
properties of the cells, this complicates an in vivo analysis of
vacuole structure. All deletions of core V-ATPase subunits
result in this “vma phenotype,” with one important excep-
tion: The a-subunit of the V-ATPase exists in two isoforms,
the vacuolar isoform Vph1p and the Golgi or endosomal
isoform Stv1p (Manolson et al., 1994). Both isoforms can
substitute for one another in proton translocation, although
they differ with respect to regulated V
 
1
 
/V
 
0
 
 dissociation that
occurs upon glucose depletion (Parra and Kane, 1998; Ka-
wasaki-Nishi et al., 2001a,b). A single deletion of either
Vph1 or Stv1 does not result in the vma phenotype and per-
mits healthy growth of the cells, also on neutral media
(Manolson et al., 1994).
 
Deletion of the V
 
0
 
 subunit Vph1p results in vacuolar 
fusion defects
 
Absence of the vma phenotype makes vph1 mutants suitable
for probing a role of V
 
0
 
 in vacuolar fusion in vivo. Mutation
of fusion-relevant components frequently results in a frag-
mentation of vacuoles into multiple small vesicles in vivo
(Raymond et al., 1992; Wada et al., 1992b). In some mu-
tants, fragmentation does not occur, for example, after muta-
tion of the v-SNARE Nyv1, Vtc1, or Vtc4 (Nichols et al.,
1997; Muller et al., 2002). We assayed the in vivo effects of
 
*Abbreviations used in this paper: BCECF, 2
 
 
 
7
 
 
 
-bis-(2-carboxyethyl)-5-
(and 6)-carboxyfluorescein; FCCP, carbonylcyanide-4-trifluormethoxyphe-
nylhydrazon;
 
 
 
pmf, proton motive force.T
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V-ATPase mutations by light microscopy after staining the
vacuolar membranes with the red fluorescent vital dye FM4–
64. Mutants lacking the vacuolar V
 
0
 
 subunit Vph1p showed
numerous small vacuolar fragments which formed clusters
(Fig. 1). This phenotype was observed with high frequency
and resembles that of mutants in other genes with a function
in the postdocking phase of vacuole fusion, such as Vtc3,
Glc7 (protein phosphatase 1), calmodulin, or Vac8 (Peters
and Mayer, 1998; Peters et al., 1999, 2001; Wang et al.,
2001b; Muller et al., 2002). In contrast, mutation of Stv1,
the Golgi/endosomal isoform of Vph1, did not result in vac-
uolar fragmentation (Fig. 1), nor did deletion of the V
 
1
 
 sub-
unit Vma1p (unpublished data; with the strong caveat that
this last mutant has the severe vma phenotype). Our results
differ from those published in another study (Perzov et al.,
2002) that reported vacuolar fragmentation for 
 
 
 
stv1 cells
but not for 
 
 
 
vph1 cells. Due to this discrepancy, we gener-
ated 
 
 
 
vph1 mutants in three independent strain back-
grounds and consistently observed vacuolar fragmentation.
Currently, we have no explanation for this difference. How-
ever, our results are strongly corroborated by an unbiased
microscopic screen for deletion mutants showing vacuolar
fragmentation (Seeley et al., 2002). This genome wide screen
identified mutants in four out of five V
 
o
 
 subunits as defective
in vacuolar morphology, reporting a particularly strong phe-
notype for 
 
 
 
vph1 but none for 
 
 
 
stv1 or 
 
 
 
vma1.
In vivo experiments provide only indirect information
about the proton uptake and fusion activities of the vacu-
oles. To overcome this limitation, we analyzed this aspect in
an in vitro system reconstituting vacuolar fusion (Conradt et
al., 1992). Vacuoles can be extracted from yeast spheroplasts
after enzymatic digestion of the cell wall and gentle lysis by
DEAE-dextrane, a treatment that leaves vacuoles intact and
fusion competent. The isolated organelles fuse upon incuba-
tion with an ATP-regenerating system and cytosolic extracts.
Since both V
 
1
 
 and V
 
0
 
 sectors are essential for proton translo-
cation activity of the V-ATPase (Stevens and Forgac, 1997;
Kane, 1999), we compared the fusion competence of vacu-
oles from V
 
1
 
 and V
 
0
 
 mutants, testing whether this V-ATPase
activity was required for vacuole fusion. Vacuoles purified
from the V
 
0
 
 mutant 
 
 
 
vph1 were deficient for in vitro fu-
sion. The fusion defect was even observed if only one of the
fusion partners was a 
 
 
 
vph1 vacuole and the other fusion
partner was a wild-type vacuole (Fig. 2 A). This suggests that
Vph1p is required for fusion on both fusion partners. Vacu-
oles from the V
 
1
 
 mutant 
 
 
 
vma1 fused with 
 
 
 
50% of wild-
type activity (Fig. 2 A). Addition of a cytosolic extract in-
creased the fusion activity of 
 
 
 
vma1 vacuoles to 70%. This
Figure 1. Vacuolar structure in V-ATPase mutants. (A) Yeast cells 
(BY4742) containing the indicated deletions of different V-ATPase 
subunits were grown logarithmically in liquid YPD medium, stained 
with FM4–64, and analyzed by fluorescence microscopy as described 
in Materials and methods. (B) Quantitation of vacuole morphology. 
The number of vacuolar vesicles (stained by FM4–64) per cell was 
determined for the strains shown in A. For each experiment, 200 
cells per strain were analyzed and grouped into the indicated 
categories. Two experiments were averaged. Bar, 5  m.
Figure 2. Fusion activity of vacuoles from strains deficient in V1 
sector ( vma1) or in V0 sector ( vph1). (A) Vacuoles from the 
indicated mutants (DKY 6281 background) were fused with wild-type 
vacuoles (BJ3505). Incubations were performed in the presence or 
absence of untreated cytosol (C) or of cytosol immunodepleted for 
Vma1p and Vma2p (dC). Fusion was assayed after 70 min at 27 C. 
The fusion activities of control reactions (asterisk) were set to 100%. 
The activity of the samples on ice was set to 0% (n   5). Fusion 
activities of the wild-type–wild-type combination ranged from 2.2 
to 4.1 U. (B) Western blot of equal protein amounts of cytosol (C) 
and immunodepleted cytosol (dC) against Vma1p, Vma2p, and the 
cytosolic marker protein phosphoglycerate kinase (PGK), verifying 
the absence of V1 sectors in the depleted cytosol.T
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activation was not due to readdition of intact V
 
1
 
 subunits via
the cytosolic extract because immunodepletion of V
 
1
 
 from
these extracts (Fig. 2 B) did not diminish their activities
(Fig. 2 A). 
 
 
 
vph1 vacuoles remained fusion incompetent
under all conditions. Since both deletions of the V
 
0
 
 subunit
Vph1 and deletion of the V
 
1
 
 subunit Vma1 completely abol-
ish the pump activity of the V-ATPase (Stevens and Forgac,
1997; Kane, 1999), the difference in fusion activity between
these strains is best explained by a function of Vph1p for
vacuolar fusion that is independent of proton translocation.
 
Vacuolar proton uptake is not limiting for fusion of 
 
 
 
vph1 vacuoles
 
Since vacuole fusion depends on a pmf across the vacuo-
lar membrane (Conradt et al., 1994; Ungermann et al.,
1999b) and the V-ATPase is the major vacuolar proton
pump (Stevens and Forgac, 1997), we asked whether the
fusion activity of 
 
 
 
vph1 vacuoles could be limited by lack
of a pmf. We tested whether 
 
 
 
vph1 vacuoles are able to
generate a basal pmf by a V-ATPase–independent pathway
and whether this pmf would be above the threshold re-
quired for fusion. V-ATPase–independent antiport mecha-
nisms can reconstitute a basal proton uptake activity by an-
tiport of, for example, amino acids and protons (Ohsumi
and Anraku, 1981, 1983; Sato et al., 1984; Klionsky et al.,
1990; Wada et al., 1992a; Wada and Anraku, 1994) and/or
 
by combination of an active vacuolar Ca
 
2
 
 
 
 pump and a
Ca
 
2
 
 
 
/H
 
 
 
 antiporter (Ohsumi and Anraku, 1983; Cun-
ningham and Fink, 1994; Forster and Kane, 2000). The
pmf as such is important to drive fusion, but for the pur-
pose of our experiments it is irrelevant whether proton up-
take occurs via the V-ATPase or alternative mechanisms.
We measured the apparent proton uptake activity of whole
vacuoles under the conditions of our fusion reaction by fol-
lowing the change in absorbance of acridine orange at 491
and 540 nm, a common assay for the vacuolar pmf (Gluck
et al., 1982). Since acridine orange is also fluorescent, we
could monitor its distribution in the membrane prepara-
tion by fluorescence microscopy. At least 92% of the dye
localized to structures that, by size and morphology, could
be identified as vacuoles (unpublished data). Therefore,
acridine orange will mostly report changes of the pmf on
vacuoles. At standard dye to membrane ratios wild-type
vacuoles showed a clear ATP-dependent decrease in the ab-
sorbance signal, indicating that a pmf had formed (Fig. 3
A, bottom panel). Addition of the protonophor carbonyl-
cyanide-4-trifluormethoxyphenylhydrazon (FCCP) at the
end of the assay period collapsed the pmf and restored the
signal to the initial values. No signal was observed in
the absence of ATP or after addition of even low concen-
trations (0.1 
 
 
 
M) of the V-ATPase inhibitor concanamy-
cin A. Concanamycin A blocks V-ATPase–dependent H
 
 
Figure 3. Detection of V-ATPase–independent proton 
uptake activity by acridine orange. (A) Concentration 
dependence of the assay. Proton uptake activity of the 
vacuoles was assayed by measuring acridine orange 
absorption. Fusion reactions were started in the presence 
of 15  M acridine orange and different vacuole 
concentrations to vary the dye to vacuole ratio. Where 
indicated (start), the ATP regenerating system and 
concanamycin A had been added. At the end of the 
assay period, FCCP (30  M) was added to dissipate 
the proton gradient. (B) Assay of mutant vacuoles. 
Vacuoles from wild-type,  vph1, and  vma2 cells 
were assayed for proton uptake activity as in A. 54 
pmol acridine orange (final concentration 15  M) 
were used per  g vacuoles.T
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translocation at nanomolar concentrations (Drose and Al-
tendorf, 1997). Our observation is consistent with earlier
results from various other groups using subvacuolar vesicles
(Drose and Altendorf, 1997). These studies demonstrated
that the V-ATPase was the main source of the vacuolar pmf
and could be completely inhibited by bafilomycin A or
concanamycin A. At lower dye to vacuole ratios (Fig. 3 A,
top two panels), however, the assay was more sensitive and
could still detect a pmf in the presence of 0.1 
 
 
 
M concana-
mycin A. 1 and 5 
 
 
 
M of the inhibitor reduced the signal
further and yielded overlapping curves, suggesting that
these concentrations had saturated the system and that
V-ATPase had been completely inhibited. Nevertheless,
significant ATP-dependent proton uptake activity remained
even at these high concentrations. This concanamycin-
insensitive activity was comparable to the levels of ATP-
dependent proton uptake observable with vacuoles pre-
pared from V
 
1
 
 (
 
 
 
vma2) or V
 
0
 
 (
 
 
 
vph1) mutant cells (Fig. 3
B). The signal in V-ATPase mutant vacuoles could not be
further reduced by concanamycin A. Therefore, this signal
appears to reflect the V-ATPase–independent part of vacu-
olar proton uptake.
Next, we asked whether the V-ATPase–independent pro-
ton uptake activity could suffice to drive fusion. We com-
pared the fusion and proton translocation activities of
 
 
 
vph1 vacuoles to those of wild-type vacuoles in which
V-ATPase pump activity had been pharmacologically sup-
pressed with concanamycin A. In this case, we measured ap-
parent proton uptake activity by following alkalinization of
the medium with the pH-sensitive dye 2
 
 
 
7
 
 
 
-bis-[2-carboxy-
ethyl]-5-[and 6]-carboxyfluorescein (BCECF; Peters et al.,
2001). Unlike acridine orange, which inserts into the vacu-
olar membrane (unpublished data), this dye is coupled to
high molecular weight dextrane, does not interfere with
vacuole fusion, and permits assay of fusion and proton
translocation in the same samples. In this assay, the appar-
ent proton translocation activity of 
 
 
 
vph1 vacuoles was
equal to that of wild-type vacuoles treated with 1 
 
 
 
M con-
canamycin A (Fig. 4 B). As in the acridine orange assay, this
signal was ATP dependent and FCCP sensitive, suggesting
that it reflected the same V-ATPase–independent compo-
nent of vacuolar proton uptake. Comparison of the fusion
activities revealed that 
 
 
 
vph1 vacuoles did not fuse, but
wild-type vacuoles with 1 
 
 
 
M concanamycin A retained
full fusion activity (Fig. 4 A). FCCP dissipates the proton
gradient across the vacuolar membrane, eliminating both its
V-ATPase–dependent and V-ATPase–independent compo-
nents. In agreement with earlier studies (Conradt et al.,
1994; Mayer et al., 1996; Ungermann et al., 1999b), FCCP
inhibited fusion. Together, vacuole fusion seems to depend
on a pmf across the vacuolar membrane but not on V-ATP-
ase proton pump activity. Hence, the fusion defect of
 
 
 
vph1 vacuoles cannot be explained by a reduction in the
apparent proton uptake activity, supporting a direct func-
tion of V
 
0
 
 in vacuole fusion.
We sought to specifically interfere with the fusion rele-
vant aspect of V
 
0
 
. Available low molecular weight V-ATP-
ase inhibitors affect only the proton translocation function
of the V-ATPase, (e.g., concanamycin A) and/or are slowly
reacting and of unsatisfactory specificity (e.g., dicyclohexyl-
carbodiimide). We raised antibodies to V0 subunits in order
to generate highly specific agents that might interfere with
V0 function and be suitable for analysis of the fusion reac-
tion. We immunized goats with the recombinantly ex-
pressed and purified NH2-terminal cytosolic part of Vph1p
and prepared affinity-purified polyclonal antibodies from
the sera. If titrated into in vitro fusion reactions, these anti-
bodies inhibited fusion in a concentration-dependent man-
ner (IC50  6  M; Fig. 5 A). Nonimmune antibodies had
no effect at comparable concentrations (Fig. 5 B). To ex-
clude potential interference due to the divalent nature of
whole IgG, we also prepared monovalent Fab fragments
from these antibodies. They also inhibited fusion at con-
centrations comparable to those observed for whole IgGs
(Fig. 5 C), matching our general experience for many other
fusion relevant components: the inhibitory potency of
whole IgGs and Fab fragments is not significantly different
(Haas et al., 1995; Haas and Wickner, 1996; Mayer and
Wickner, 1997; Nichols et al., 1997).
As described for the  vph1 mutants above, we tested
whether antibodies to Vph1p would interfere with the ap-
parent vacuolar proton uptake. This was not the case, al-
though the antibodies blocked fusion (Fig. 6). The lack of
effect of anti-Vph1p on proton uptake is probably due to
the fact that the antibodies recognize only solitary V0 sectors
but not the assembled V0/V1 holoenzyme (unpublished
data). The antibodies were also tested on vacuoles from
which the V1 sector had been removed by cold extraction
with KSCN and ATP, a treatment that leaves the V0 sector
in the membranes (Arai et al., 1989; Moriyama and Nelson,
1989; Adachi et al., 1990; Peters et al., 2001) but inactivates
V-ATPase–dependent proton translocation (Fig. 7 B). Fu-
sion of such vacuoles was inhibited by anti-Vph1p as effi-
ciently as by GTP S or antibodies to Sec18p/NSF (Fig. 7
A), two established antagonists of vacuole fusion (Haas et
Figure 4. Fusion and apparent proton translocation activity of 
vacuoles from vph1 deletion strains ( vph1). (A) Fusion and apparent 
proton translocation activity (B) were examined in parallel fusion 
reactions using wild-type or  vph1 vacuoles in the presence or 
absence of concanamycin A (Conc.A; 1  M) or FCCP (30  M). 
Fusion and pump activities of wild-type vacuoles (asterisk) were set 
to 100% (n   3). Fusion activities of these control samples ranged 
from 2.5 to 3.8 U.T
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al., 1994; Mayer et al., 1996). Thus, antibodies to the cyto-
solic part of Vph1p provide an additional tool to separate
the fusion function of V0 from its role in proton pumping.
Vph1p acts in the postdocking phase of vacuole fusion
The antibodies to Vph1p were used for kinetic analyses in
order to explore which stage of vacuole fusion required
Vph1p. First, we tested when the reaction became resistant
to anti-Vph1p (Fig. 8 A). The majority of vacuoles com-
pletes distinct reaction steps within defined intervals and be-
comes resistant to inhibitors of these steps (Conradt et al.,
1994; Mayer et al., 1996), revealing the sequence of events.
Inhibitors were added to an aliquot of an ongoing fusion re-
action at different times after the start point. Then, the incu-
bation was continued until the end of a standard fusion pe-
riod (70 min). Another aliquot was chilled to stop fusion at
the time of inhibitor addition. All inhibitors abolished fu-
sion when added at the start of the reaction (Fig. 8 A). Af-
ter 35 min, the reaction was resistant to antibodies to the
t-SNARE Vam3p, indicating the completion of docking
(Mayer and Wickner, 1997; Ungermann et al., 1998b). The
inhibition curve for anti-Vph1p lagged significantly behind
that for anti-Vam3p, suggesting that Vph1p was required
past the docking stage. This behavior resembled the inhibi-
tion curves obtained previously with calmodulin antagonists
or with the Ca
2  chelator BAPTA, which inhibit completion
of fusion after the docking step (Peters and Mayer, 1998;
Ungermann et al., 1999b).
Trans-SNARE pairing is believed to be a key event in
docking membranes and committing them to fusion (Sollner
et al., 1993; Weber et al., 1998). It can be assayed as a molec-
ular indicator of docking (Ungermann et al., 1998b). To test
whether deletion of Vph1 affected a step before or concomi-
tant with docking, or rather an event required for subsequent
fusion per se, we tested whether  vph1 vacuoles were able to
form trans-SNARE complexes. Yeast vacuoles offer the possi-
bility to measure trans-SNARE pairing by use of a com-
bination of vacuoles lacking either the vacuolar v-SNARE
Nyv1p or the vacuolar t-SNARE Vam3p (Ungermann et
al., 1998b). These vacuoles are prepared from separate
strains and mixed in vitro. v/t-SNARE complexes can only
Figure 6. Influence of antibodies to Vph1p on the apparent proton 
translocation and fusion activity of intact vacuoles. Standard fusion 
reactions were run in the presence or absence of the indicated 
inhibitors. Pump activity was determined with the BCECF assay as 
described in Materials and methods. Fusion activities were assayed 
in parallel samples as in Fig. 2 (n   4). Fusion activities of control 
samples ranged from 3.3 to 4.8 U. Inhibitors were FCCP (30  M), 
anti-Vph1p (20  M), and nonimmune antibodies (20  M).
Figure 5. Inhibition by antibodies to Vph1p. (A) Different 
concentrations of affinity-purified antibodies to Vph1p (from goat) 
were added to a standard fusion reaction without cytosol. The reaction 
was started after preincubation for 10 min on ice by adding ATP. 
Fusion was assayed after 70 min at 27 C. (B) Nonimmune antibodies 
do not interfere with vacuole fusion. Standard fusion reactions were 
run with 20  M IgG purified from nonimmune or anti-Vph1p sera 
from goats, or with control buffer only, and assayed after 70 min at 
27 C (n   6). (C) Inhibition of fusion by Fab fragments of antibodies to 
Vph1p. Standard fusion reactions were incubated with Fab fragments 
derived either from nonimmune antibodies or from antibodies to 
Vph1p. Fusion was assayed as in the legend to Fig. 2 (n   3). Fusion 
activities of the control samples (asterisk) ranged from 3.2 to 5.1 U, and 
those of ice values ranged from 0.2 to 0.3 U. Inhibitor concentrations 
were 45  M anti-Vph1p Fab and 45  M nonimmune Fab.T
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be formed if a v-SNARE–containing vacuole docks to a
t-SNARE–containing vacuole. If this experiment is per-
formed in the presence of a late acting fusion inhibitor, such
as GTP S, accumulating SNARE complexes represent trans-
complexes. We generated a strain carrying deletions of Vam3
(t-SNARE) and Vph1. Vacuoles from this strain were fused
with vacuoles from a  nyv1 (v-SNARE) strain. In agreement
with previous results (Ungermann et al., 1998b), SNARE
complexes accumulated at 27 C but not on ice (Fig. 8 B).
There was no significant difference in the yield of trans-
SNARE pairing between VPH1–containing vacuoles and
 vph1 vacuoles. The docking inhibitor Gdi1p, which ex-
tracts the Rab-GTPase Ypt7p from the membranes, sup-
pressed formation of trans-SNARE complexes, demonstrat-
ing that the signal from the coimmunoprecipitation assay was
specific and a consequence of docking. GTP S, which per-
mits docking and the formation of V0 transcomplexes (Peters
et al., 2001) but not fusion, did not interfere with trans-
SNARE pairing. Since trans-SNARE pairing depends on a
pmf (Ungermann et al., 1999b), this experiment also indi-
cates that the apparent proton uptake activity of  vph1 vacu-
oles sufficed to drive trans-SNARE pairing. More impor-
tantly, however, it demonstrates that  vph1 vacuoles do not
fuse (Fig. 2), although they form trans-SNARE complexes
(Fig. 8 B), indicating that a step subsequent to or indepen-
dent of trans-SNARE pairing is blocked by deletion of Vph1.
Figure 8. Kinetic resolution of Vph1p requirement for fusion. 
(A) Standard fusion reactions without cytosol were started at 
27 C. At the indicated times, inhibitors or control buffer were 
added. The samples were left on ice for 10 min. Then, they were 
transferred to 27 C or left on ice for the remainder of the 70-min 
reaction period. After 70 min, fusion activity was assayed. (B) Trans-
SNARE pairing. Fusion reactions with vacuoles from strains SBY521 
( vam3  vph1) or no. 418 ( vam3 VPH1) and no. 120 ( nyv1 
VPH1) were incubated (50 min, 27 C) with the indicated inhibitors 
at 27 C or left on ice. Then, the membranes were reisolated, 
solubilized, and assayed for trans-SNARE complexes by determining 
the amounts of the v-SNARE Nyv1p coimmunoprecipitating with 
the t-SNARE Vam3p. (C) Standard fusion reactions without cytosol 
were incubated at 27 C in the presence of 1 mM MgCl2 and 5 mM 
BAPTA for 30 min. The reactions were chilled on ice, and vacuoles 
were reisolated (10,000 g, 2 min, 2 C). Vacuoles were resuspended 
in fusion buffer with cytosol and 200  M CaCl2 but without ATP. 
Aliquots were preincubated for 5 min on ice with the indicated 
inhibitors and incubated further for 70 min at 27 C. Fusion activities 
were assayed and plotted as in the legend to Fig. 2 (n   3). Activities 
of the control sample ranged from 1.1 to 1.9 U. Inhibitors were 
BAPTA (5 mM), GTP S (2 mM), anti-Vam3p (2  M), Gdi1p (5  M), 
anti-Vph1p (20  M), and FCCP (30  M).
Figure 7. Fusion of vacuoles without V1 sector is inhibited by 
anti-Vph1p. (A) Vacuoles were extracted with SCN
 /ATP to 
remove V1. Fusion activity was assayed in the absence or presence 
of the indicated inhibitors as in the legend to Fig. 2 (n   3). Fusion 
activities of the control samples (asterisk) ranged from 0.75 to 1.4 U. 
(B) Apparent proton pumping activity of untreated or stripped vacuoles 
was determined as described in Materials and methods. The activity 
of untreated vacuoles was set to 100%. Inhibitors were GTP S (2 mM), 
anti-Vph1p (20  M), nonimmune antibodies (20  M), and anti-
Sec18p (2  M).T
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Coupling of Vph1p to the Ca
2 -releasing channel
Docking triggers a Ca
2  release from the vacuolar lumen
that strengthens the binding of calmodulin to the vacuolar
membrane and triggers fusion (Peters and Mayer, 1998).
We tested whether Vph1p function would even be required
after the Ca
2 /calmodulin-dependent step by accumulating
reaction intermediates in the presence of the Ca
2  chelator
BAPTA. This reversible block can be relieved by removing
BAPTA and replenishing Ca
2  (Ungermann et al., 1999b).
Completion of the reaction from this stage still showed sig-
nificant sensitivity to anti-Vph1p (Fig. 8 C), although the
effect was not as pronounced as for the low molecular weight
inhibitor GTP S. This suggests that the antibody-sensitive
stage might be tightly coupled to the Ca
2 -requiring step
and/or be overcome rapidly after removal of BAPTA. The
requirement for Vph1p can obviously not be completely sat-
isfied before completion of the Ca
2 /calmodulin-dependent
step. Together, the results from the kinetic analysis (Fig. 8
A), the direct assay of trans-SNARE pairing (Fig. 8 B), and
the staging experiments (Fig. 8 C) all suggest that Vph1p
functions after the completion of docking and trans-SNARE
pairing, concomitant with or after the release of lumenal
Ca
2  and close to the completion of fusion.
The relationship of Ca
2  release and Vph1p function in fu-
sion was further characterized by monitoring Ca
2  release in
the course of fusion. Fusion reactions were run in the pres-
ence of aequorin and coelenterazine (Muller et al., 2001). Ae-
quorin is a protein that oxidizes its substrate coelenterazine in
a Ca
2 -dependent fashion, emitting light (Shimomura et al.,
1993). This permits continuous recording of Ca
2  levels in
the buffer of ongoing fusion reactions. In agreement with pre-
vious results obtained with a different approach (Peters and
Mayer, 1998), treatments preventing priming, such as anti-
bodies to Sec18p/NSF or Sec17p/ -SNAP, suppressed the re-
lease of Ca
2  from the vacuolar lumen (Fig. 9 A). Docking in-
hibitors, such as antibodies to the t-SNAREs Vam3p and
Vam7p had the same effect (not depicted). Surprisingly, anti-
bodies to Vph1p also inhibited Ca
2  release, suggesting that
either Vph1p or V0 itself might be involved in Ca
2  release or
that Vph1p might be coupled to the Ca
2  channel. In both
cases, adding an antibody to Vph1p might block a conforma-
tional change required for activation of the channel. Only in
the first case, however, should deletion of Vph1p, which
eliminates the vacuolar V0 sector as a whole (Stevens and For-
gac, 1997; Kane and Parra, 2000), abolish Ca
2  release. This
was not the case.  vph1 vacuoles showed Ca
2 efflux just as
their wild-type counterparts (Fig. 9 B). Efflux was sensitive to
the Rab-GTPase inhibitor Gdi1p, demonstrating that it de-
pended on docking and was triggered by the authentic fusion
pathway. This permits several conclusions. First, it suggests
that the fusion defect of  vph1 vacuoles is not due to the in-
ability to release calcium. Second, Vph1p itself is not part of
the Ca
2 -releasing channel. Third, Vph1p may be coupled to
the Ca
2  channel, leaving calcium release intact if Vph1p is
absent but blocking it if Vph1p is inactivated by an antibody.
Discussion
A previous study demonstrated that V0 sectors from oppos-
ing vacuolar membranes can associate into transcomplexes
before fusion has occurred (Peters et al., 2001). Vacuolar V0
sectors consist of a cylinder composed of (probably six) pro-
teolipids, the large multispanning integral membrane pro-
tein Vph1p, and the peripheral subunit Vma6p (Kane et al.,
1989; Hirata et al., 1997; Powell et al., 2000). V0 transcom-
plexes might thus connect proteolipid cylinders from oppos-
ing membranes, creating a condition that might resemble
the situation postulated in pore models of fusion (Lindau
and Almers, 1995; Zimmerberg, 2001). Formation of V0
transcomplexes requires ATP, the Rab-GTPase Ypt7p, and
trans-SNARE pairing. Therefore, it depends on the early re-
action steps of priming and docking (Peters et al., 2001).
Maintenance of V0 transcomplexes is independent of trans-
SNARE pairing. These observations link V0 transcomplex
formation into the reaction sequence. It is important, how-
ever, to investigate whether V0 is required in the final stage
of fusion. The results presented here address this aspect.
First, we demonstrate that V0 does not only form trans-
complexes but is critically involved in vacuole fusion in vitro
Figure 9. Vacuolar Ca
2  release during fusion. (A) Inhibition by 
antibodies to Vph1p. Standard fusion reactions were started, and 
Ca
2  was monitored continuously as described in the Materials and 
methods. Before the reactions were started, vacuoles had been 
preincubated with one of the indicated inhibitors, or with one of the 
following buffers only (3 min, 0 C): anti-Sec18p (2  M), anti-Sec17p 
(2  M), anti-Vph1p (20  M), and nonimmune antibodies (20  M). 
(B) Effect of vph1 deletion. Vacuoles were prepared from wild-type 
and  vph1 cells and incubated under fusion conditions in the 
presence or absence of 5  M Gdi1p. Ca
2  efflux was monitored as 
in A, and peak signals were plotted.T
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and in vivo. The V0 requirement kinetically mapped to the
reaction phase that follows completion of docking and trans-
SNARE pairing (Ungermann et al., 1998b) and is indepen-
dent of a proton gradient (Mayer et al., 1996; Mayer and
Wickner, 1997; Ungermann et al., 1999b). However, this
terminal reaction phase depends on Ca
2  release from the
vacuolar lumen which triggers bilayer fusion (Peters and
Mayer, 1998). This is consistent with the observation that
V0 transcomplexes form after docking and depend on Ca
2 
release (Peters et al., 2001). It establishes a correlation be-
tween the timing of V0 function in fusion and V0 trans-
complex formation, strengthening the hypothesis that V0
transcomplex formation is tied to V0 function in vacuole
fusion. Second, we demonstrate that Vph1p is required
on both fusion partners. This symmetric requirement for
Vph1p is consistent with a feature of some published pore
models, namely that two membrane integral multisubunit
cylinders connect the two membranes before fusion (Lindau
and Almers, 1995; Zimmerberg, 2001).
Several lines of evidence suggest that trans-SNARE pair-
ing is a necessary intermediate in vacuole fusion but that fur-
ther events are required to drive the transition from docking
to full fusion. First, quenching of the Ca
2  efflux by BAPTA
reduces fusion activity to 10% of the control samples (Peters
and Mayer, 1998), although BAPTA permits trans-SNARE
pairing (Ungermann et al., 1999b). However, BAPTA
blocks V0 transcomplex formation completely (Peters et al.,
2001). Second, deletion of Vtc3 permits docking of the vac-
uoles, Ca
2  release, and V0 transcomplex formation but not
fusion (Muller et al., 2002). Third, inactivation of V0 by de-
letion of Vph1p reduced fusion activity to 10–15% of the
control value, although trans-SNARE pairing was unaf-
fected. This demonstrates that V0 is crucial for most of the
observable fusion activity of vacuoles. Fourth, trans-SNARE
complexes appear to be largely dispensable after the BAPTA-
sensitive stage (Ungermann et al., 1998a, 1999b) but V0 is
not. This correlates to the behavior of V0 transcomplexes
because docking and trans-SNARE pairing are required to
establish V0 transcomplexes. Once formed, however, V0
transcomplexes persist in the absence of SNARE complexes
(Peters et al., 2001).
The 10–15% of fusion activity observed after V0 inactiva-
tion is probably caused by trans-SNARE complexes, reflect-
ing a basal level of fusion that may result from forcing the
membranes into close proximity. It is possible that this ba-
sal activity is what could be reconstituted with purified
SNAREs in liposomes. Although these liposomes contained
high concentrations of SNAREs, they yielded significantly
lower fusion rates than the equivalent complete fusion sys-
tem can show in situ (Weber et al., 1998; Parlati et al.,
1999). Lowering the v-SNARE concentration in liposomes
to roughly physiological levels abolished this fusion activity
(Mahal et al., 2002). It made the system completely de-
pendent on an additional factor, the exocytic Ca
2  sensor
synaptotagmin. Synaptotagmin strongly stimulated fusion,
though in this case in a Ca
2 -independent fashion.
It appears that both in triggered fusion events, such as reg-
ulated exocytosis, and in “constitutive” fusion events, such
as vacuole fusion, the membranes require additional factors
to efficiently progress from docking and trans-SNARE pair-
ing to fusion. Such a function may be fulfilled by synap-
totagmin in regulated exocytosis (Fernandez-Chacon et al.,
2001; Chapman, 2002) or by V0 and Vtc3p in vacuole fu-
sion. It is possible that proteins with related properties par-
ticipate in other membrane fusion reactions. Candidates ex-
ist, as exemplified by Got1p and Sft2p, tetraspanning
membrane proteins with a genetic interaction with the
t-SNARE Sed5p and some similarities to the V0 proteolip-
ids. Got1p is required in a postdocking stage of ER-Golgi
trafficking and forms multimeric assemblies in the membrane
(Conchon et al., 1999). SCAMP2 was identified as a factor
required for endocytosis but also for a very late step in mast
cell exocytosis. SCAMP2 is also a tetraspanning membrane
protein that belongs to a protein family with members on
various compartments, exists as a multimeric complex in the
membrane, and binds to the t-SNARE subunit SNAP-23
(Singleton et al., 1997; Fernandez-Chacon et al., 2000;
Fernandez-Chacon and Sudhof, 2000; Guo et al., 2002).
Ca
2  is released from the vacuolar lumen in a way that de-
pends on priming and docking (Peters and Mayer, 1998).
Now we have discovered that inactivation of the V0 subunit
Vph1p by antibodies prevents this release, but deletion of
Vph1p does not. Since inactivation of Vph1p by deletion or
antibodies interferes neither with priming nor with docking
(Fig. 8 B; unpublished data), we propose that the effect of
Vph1p antibodies on Ca
2  release may reflect a coupling of
Vph1p to the putative Ca
2  channel. Whether this coupling
would be direct or indirect via shared binding partners can-
not be judged at the moment. But it is striking that V0 is as-
sociated with the t-SNARE Vam3p (Peters et al., 2001) and
that t-SNAREs in regulated exocytosis were shown to specifi-
cally bind to calcium channels (Leveque et al., 1994; Sheng et
al., 1994). Our hypothesis is further supported by the differ-
ential effects of Ca
2  chelators on fusion (Peters and Mayer,
1998). Only BAPTA, a Ca
2  chelator with a rapid associa-
tion rate, can block fusion. EGTA, which has a comparable
Kd for Ca
2  but a much slower association rate, is not effec-
tive. This difference is best explained by assuming that the
site of Ca
2  release and the Ca
2  effector proteins (in case of
the vacuoles the effectors are most likely V0 and calmodulin
[Peters et al., 2001]) are tightly associated. Then, chelators
must act rapidly to be able to quench Ca
2  before it diffuses
to and binds its receptor site (Neher, 1998). An analogous
situation exists in regulated exocytosis. The triggering stage of
this reaction is only sensitive to fast Ca
2  chelators (Adler et
al., 1991), and the Ca
2  channels are associated with syntaxin
(t-SNARE) in the plasma membrane (Leveque et al., 1994;
Sheng et al., 1994). They should hence be close to the fusion
site. This provides a physical correlate for the differential sen-
sitivity of exocytosis to BAPTA and EGTA.
The reconstituted proteolipid cylinder of the V-ATPase
can form large pores in response to binding of Ca
2  and cal-
modulin, demonstrating a potential for significant confor-
mational changes in the membrane (Peters et al., 2001). On
the other hand, a fraction of V0 in vacuolar membranes is as-
sociated with the VTC complex, a membrane integral com-
plex that is required for the priming activity of Sec18p/NSF
(Muller et al., 2002) and for membrane binding of LMA1,
i.e., it is coupled to two components that are directly in-
volved in generating (Sec18p; Mayer et al., 1996; Unger-T
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mann et al., 1998a) or maintaining (LMA1; Mayer and
Wickner, 1997; Xu et al., 1997) an activated state of the fu-
sion machinery. Therefore, we speculate that Vph1p, or the
entire V0 sector, might undergo significant conformational
changes during fusion, perhaps driven by Sec18p/NSF.
Antibodies to Vph1p may prevent such conformational
changes and thereby also block Ca
2  release through a chan-
nel associated with V0. Such coupling should be functionally
relevant because Ca
2  release from the lumen of an organelle
can only be transient. If the fusion system is not competent
to respond to Ca
2  at the time of release, the reaction might
be nonproductive. One might expect higher efficiency of the
overall process if Ca
2  release and the Ca
2  controlled fusion
system were activated in a coordinated fashion. This ques-
tion can be answered with certainty only once the Ca
2 -releas-
ing channel will have been identified and assays for confor-
mational changes of V0 during fusion will be available.
Materials and methods
Strains
BJ3505 and DKY6281 are standard fusion strains (Mayer et al., 1996).
Strain no. 120 is BJ3505 ( nyv1) (Nichols et al., 1997). Strain no. 418 is
DKY 6281  vam3 provided by Christian Ungerman (Biochemiezentrum,
Heidelberg, Germany). SBY521 ( vam3,  vph1) was derived from no. 418
by replacing VPH1 with a kanamycin resistance cassette as described be-
low. BY4742 (Mat   his3 1 leu2 0 met15 0 ura3 0) and its  vph1::
kanMX4 or  stv1::kanMX4 derivates were purchased from EUROSCARF.
Deletion strains of VPH1 were made by replacing the gene with a loxP-
kanMX-loxP cassette from plasmid pUG6 (Guldener et al., 1996) using the
following primers: Vph1 forward K.O., GCCTCTCAATATATCTATACT-
TGCTTAGAGGGCTACCTGTGTCAGCTGAAGCTTCGTACGC and Vph1
reverse K.O., CTGGTGGATTGGATTGCAAGTCTAACGTTTTCATGAG-
ATAAGGCATAGGCCACTAGTGGATCTG. Vma1 and Vma2 were deleted
by replacement with the HIS3 cassette from plasmid pRS 303 using the fol-
lowing primers: VMA1 forward, ATGGCTGGTGCAATTGAAAAGCTCG-
TAAGGAAATAAAAAGAATCAGATTGTACTGAGAGTGCAC, VMA1 re-
verse, CAGACAAGGCCGATTTACAACTAATTGAACAACTTGTTCCTG-
TGCGGTATTTCACACCG, VMA2 forward, GGTGTGAACGGTCCATT-
AGTCATTTGGAAAAGGTCAAGTTCCCAGATTGTACTGAGAGTGCAC,
and VMA2 reverse, GAATCTTTGGGGAGATTCTATTCAACATCTCCTTA-
GGGTAGCTGTGCGGTATTTCACACCG. All deletions were verified by
diagnostic colony PCR and by Western blotting of purified vacuoles from
the mutants.
General procedures
Vacuole isolation, cytosol preparation, fusion, purification of antibodies or
Gdi1p, inhibitors, and FM4–64 staining were as described (Peters and
Mayer, 1998; Peters et al., 1999). PS buffer is 10 mM Pipes/KOH, pH 6.8,
and 200 mM sorbitol. 1  PIC is a protease inhibitor cocktail: 100  M pe-
fabloc SC, 100 ng/ml leupeptin, 50  M o-phenanthroline, and 500 ng/ml
pepstatin A. Vacuoles without V1 sector were prepared as described (Peters
et al., 2001). In experiments with BAPTA, the alkaline phosphatase assay
mixture contained 10 mM CaCl2. All samples were centrifuged (1 min, 14,
000 g) before spectrophotometry to remove precipitated Ca
2  salts.
Proton uptake activity of vacuoles
BCECF assay. For the determination of pump activity, 100- l fusion reac-
tions were incubated at 25 C with 0.5  M BCECF-dextran (70 K; Molecu-
lar Probes). The change of fluorescence was measured at an excitation of
490 nm and an emission of 520 nm in a Perkin Elmer LS50B fluorometer
or in a plate reader fluorometer (Spectra Max Gemini; Molecular Devices).
Initial pump activity was determined as described (Peters et al., 2001). In
brief, the pH shift in the medium was followed via the pH-dependent shift
in fluorescence of BCECF. This shift could be calibrated by buffering the
solution to different pH values using PS buffer with 150 mM KCl.
Acridine orange assay. Proton uptake of vacuoles was measured essen-
tially as described. The absorbance changes of acridine orange at 491 and
540 nm were followed in a Beckman Coulter DU-600 spectrophotometer
(Gluck et al., 1982). The difference between these values at any time point
serves as a measure of the vacuolar pmf. The reaction mixture in a final
volume of 100  l contained 20  g of vacuoles under standard fusion con-
ditions with 15  M acridine orange. The reaction was started by the addi-
tion of 5  l of ATP regenerating system. At the end, 30  M FCCP were
added. Proton uptake activity was defined as the absorbance change in the
first 20 s of the reaction.
Trans-SNARE assay
120- l fusion reactions (containing 24- g vacuoles) with cytosol (0.5  g/
 l) were incubated for 50 min. The reactions were stopped by chilling the
samples on ice. 380  l of precipitation buffer were added (150 mM KCl,
1.3% [wt/vol] Triton X-100, 1.3 mM PMSF, 1.2  PIC, 13 mM EDTA, 200
mM Sorbitol, 10 mM Pipes/KOH, pH 6.8). Samples were shaken (10 min,
4 C) and centrifuged (21,000 g, 10 min). 450  l of the solubilisate were
transferred to a new reaction tube. 3% of the volume was kept as load con-
trol. 14  g of affinity-purified anti-Vam3p antibody and 100  l of a 1:4
slurry of protein A–Sepharose CL-4B (Amersham Biosciences) preequili-
brated in washing buffer (150 mM KCl, 1% [wt/vol] Triton X-100, 1 mM
PMSF, 1  PIC, 10 mM EDTA, 200 mM Sorbitol, 10 mM Pipes/KOH, pH
6.8) were added to each sample. After 1 h of shaking at 4 C, the protein
A–Sepharose was washed three times with washing buffer. Residual liquid
was removed with a Hamilton pipette. 80  l SDS sample buffer was added,
and aliquots were analyzed by gel electrophoresis and Western blotting.
Generation of antibodies to Vph1p
Vph1 cytosolic domain (Vph1-Cyt) was cloned with an NH2-terminal His6
tag for expression in Escherichia coli. The coding region of this domain
was amplified by PCR using primers cyt Vph1 forward, GCAGAGAAG-
GAGGAAGCGATTTTTC, cyt Vph1 reverse, TCACTGGACTTCAATTT-
GATCGGT, and genomic DNA as a template. The PCR product was
cloned into pCR T7/NT-TOPO (Invitrogen). The resulting plasmid was
transformed into E. coli BL21. Cells were grown in LB/Ampicillin medium
(37 C, 225 rpm) to an OD600 of  0.6. Expression was induced with 1 mM
IPTG at 37 C for 4 h. Cells were harvested by centrifugation (10,000 g, 7
min), washed with twofold-concentrated PBS, and lysed by two freeze–
thaw cycles and sonication in twofold-concentrated PBS, 8 M urea. The ly-
sate (50 ml out of 8 liters culture) was centrifuged (20,000 g, 15 min, 4 C)
and batch incubated with Ni-NTA resin (1 ml bed volume, 2 h, 4 C). The
resin was washed with 20 ml of twofold-concentrated PBS, 0.05% SDS
and with 20 ml twofold-concentrated PBS, 0.05% SDS, and 10 mM imida-
zole. Urea was omitted during washing to avoid interference in the follow-
ing coupling reaction. 0.05% SDS was added to avoid precipitation during
elution from the column. The protein was eluted with 150 mM imidazole.
The eluate (containing 3 mg of protein) was directly coupled (1 h, RT) to
1.5 ml CH-activated Sepharose 4 B (Amersham Biosciences).
Antibodies to Vph1-Cyt were raised by injecting purified recombinant
protein eluate (300–500  g per boost) into a goat. Serum (10 ml) was affin-
ity purified using the recombinant protein immobilized on activated CH–
Sepharose 4B. The serum was diluted with 1 vol PBS and passed over the
column at RT. The column was washed with 20–25 column volumes of
PBS. Antibodies were eluted with 0.1 M glycine pH 2.75/150 mM NaCl,
and the pH was immediately neutralized by adding 1 M Tris/HCl, pH 8.8.
The antibodies were transferred into PS buffer with 150 mM KCl by re-
peated dilution and ultrafiltration in centricon-30 (Amicon) and stored at
 20 C. Control antibodies were affinity purified with protein G from pre-
immune serum and treated as above.
Preparation of Fab fragments
Fab fragments were prepared from Vph1p antibodies essentially according
to the manufacturer’s instructions (ImmunoPure Fab Preparation kit; Pierce
Chemical Co.). 20 mg of purified antibody were diluted with 1 vol of di-
gestion buffer (as supplied). The solution (2 ml) was incubated overnight at
30 C with 0.5 ml immobilized papain. The sample was centrifuged, and
the supernatant was passed over a protein G column to remove uncleaved
antibodies and Fc Fragments. The flowthrough containing the Fab fragments
was repeatedly diluted and concentrated to exchange the buffer for PS
with 150 mM KCl.
Ca
2  assay
Ca
2  release from vacuoles in the course of the fusion reaction was as-
sayed similarly as described (Peters and Mayer, 1998) with the following
modifications. Ca
2  was directly measured with aequorin in ongoing fu-
sion reactions running in parallel in a microtiter plate luminometer (EG&G
Berthold). Reactions (30  l) contained 10  g of vacuoles from strain
BJ3505 in PS buffer with 150 mM KCl and 0.5  l cytosol (30 mg/ml). Re-
spective inhibitors were included. After 2 min of preincubation on ice, 2
 l of ATP regenerating system (same composition as in the fusion assay)T
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and 3  l of a freshly prepared 2:2:1 mix of the following stock solutions
were added: 2.5  M aequorin (Aqualite; Molecular Probes), 1 mM EGTA/
KOH, pH 7.5, and 500  M native coelenterazine (Molecular Probes) in
EtOH. Samples were pipetted into a microtiter plate, and light emission of
aequorin was measured with the luminometer for 60 min at 27 C. The as-
say was calibrated with solutions of different calcium concentrations as
described (Peters and Mayer, 1998).
FM4–64 staining
Cells were grown logarithmically in liquid YPD overnight (OD600   2) at
30 C. Cells were harvested (2 min, 3,000 g), resuspended in YPD with 10
 M FM4–64 at OD600   1, and shaken for 3 h at 30 C. Cells were harvested
as above, resuspended in YPD at OD600   0.2, and shaken for 2–3 h at
30 C. For microscopy, individual samples were removed from the shaker.
Cells were harvested (1 min, 3,000 g), resuspended in YPD at OD600   10,
and immediately analyzed by fluorescence microscopy. For quantitation of
vacuole morphology, photos of at least 20 random fields were taken. Vacu-
oles were counted in at least 200 cells per experiment and condition.
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